Literature DB >> 19825933

Clinical trial for Fabry disease faces continuing hurdles.

Ann Silversides.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825933      PMCID: PMC2780509          DOI: 10.1503/cmaj.109-3071

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

Review 1.  Update on role of agalsidase alfa in management of Fabry disease.

Authors:  Uma Ramaswami
Journal:  Drug Des Devel Ther       Date:  2011-03-14       Impact factor: 4.162

2.  Politics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.

Authors:  Danielle Bishop; Joel Lexchin
Journal:  BMC Health Serv Res       Date:  2013-03-09       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.